204 related articles for article (PubMed ID: 27624799)
1. An APOC3 3'UTR variant associated with plasma triglycerides levels and coronary heart disease by creating a functional miR-4271 binding site.
Hu SL; Cui GL; Huang J; Jiang JG; Wang DW
Sci Rep; 2016 Sep; 6():32700. PubMed ID: 27624799
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for a liver or intestinal miRNA regulation involved in the hypertriglyceridemic effect of APOC3 3'UTR variant SstI.
Dancer M; Caussy C; Di Filippo M; Moulin P; Marçais C; Charrière S
Atherosclerosis; 2016 Dec; 255():6-10. PubMed ID: 27794214
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.
Cui F; Li K; Li Y; Zhang X; An C
Lipids Health Dis; 2014 Nov; 13():170. PubMed ID: 25380998
[TBL] [Abstract][Full Text] [Related]
5. Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
; Crosby J; Peloso GM; Auer PL; Crosslin DR; Stitziel NO; Lange LA; Lu Y; Tang ZZ; Zhang H; Hindy G; Masca N; Stirrups K; Kanoni S; Do R; Jun G; Hu Y; Kang HM; Xue C; Goel A; Farrall M; Duga S; Merlini PA; Asselta R; Girelli D; Olivieri O; Martinelli N; Yin W; Reilly D; Speliotes E; Fox CS; Hveem K; Holmen OL; Nikpay M; Farlow DN; Assimes TL; Franceschini N; Robinson J; North KE; Martin LW; DePristo M; Gupta N; Escher SA; Jansson JH; Van Zuydam N; Palmer CN; Wareham N; Koch W; Meitinger T; Peters A; Lieb W; Erbel R; Konig IR; Kruppa J; Degenhardt F; Gottesman O; Bottinger EP; O'Donnell CJ; Psaty BM; Ballantyne CM; Abecasis G; Ordovas JM; Melander O; Watkins H; Orho-Melander M; Ardissino D; Loos RJ; McPherson R; Willer CJ; Erdmann J; Hall AS; Samani NJ; Deloukas P; Schunkert H; Wilson JG; Kooperberg C; Rich SS; Tracy RP; Lin DY; Altshuler D; Gabriel S; Nickerson DA; Jarvik GP; Cupples LA; Reiner AP; Boerwinkle E; Kathiresan S
N Engl J Med; 2014 Jul; 371(1):22-31. PubMed ID: 24941081
[TBL] [Abstract][Full Text] [Related]
6. Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhage.
Jiang Y; Ma J; Li H; Liu Y; You C
Lipids Health Dis; 2015 May; 14():48. PubMed ID: 25994187
[TBL] [Abstract][Full Text] [Related]
7. Multiple microRNA regulation of lipoprotein lipase gene abolished by 3'UTR polymorphisms in a triglyceride-lowering haplotype harboring p.Ser474Ter.
Caussy C; Charrière S; Meirhaeghe A; Dallongeville J; Lefai E; Rome S; Cuerq C; Euthine V; Delay M; Marmontel O; Di Filippo M; Lagarde M; Moulin P; Marçais C
Atherosclerosis; 2016 Mar; 246():280-6. PubMed ID: 26820803
[TBL] [Abstract][Full Text] [Related]
8. A functional variant in the 3'-UTR of angiopoietin-1 might reduce stroke risk by interfering with the binding efficiency of microRNA 211.
Chen J; Yang T; Yu H; Sun K; Shi Y; Song W; Bai Y; Wang X; Lou K; Song Y; Zhang Y; Hui R
Hum Mol Genet; 2010 Jun; 19(12):2524-33. PubMed ID: 20378606
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis.
Liu ME; Liao YC; Lin RT; Wang YS; Hsi E; Lin HF; Chen KC; Juo SH
Atherosclerosis; 2013 May; 228(1):161-7. PubMed ID: 23497787
[TBL] [Abstract][Full Text] [Related]
10. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease.
Jørgensen AB; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
N Engl J Med; 2014 Jul; 371(1):32-41. PubMed ID: 24941082
[TBL] [Abstract][Full Text] [Related]
11.
Xu QY; Li H; Cao HX; Pan Q; Fan JG
Biomed Res Int; 2020; 2020():8869674. PubMed ID: 33294458
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein C3 Gene Variants and Risk of Developing Type 2 Diabetes in Saudi Subjects.
Alharbi KK; Hussain T; Alharbi FK; Tabassum SN; Mohammed AA; Gambhir D; Khan IA
Metab Syndr Relat Disord; 2015 Sep; 13(7):298-303. PubMed ID: 26247234
[TBL] [Abstract][Full Text] [Related]
13. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
15. Relationship between single nucleotide polymorphisms in the 3'UTR of amyloid precursor protein and risk of Alzheimer's disease and its mechanism.
Zhou Q; Luo L; Wang X; Li X
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30914454
[No Abstract] [Full Text] [Related]
16. A 3'UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility.
Cipolla GA; Park JK; de Oliveira LA; Lobo-Alves SC; de Almeida RC; Farias TD; Lemos Dde S; Malheiros D; Lavker RM; Petzl-Erler ML
Biochim Biophys Acta; 2016 Oct; 1859(10):1306-13. PubMed ID: 27424220
[TBL] [Abstract][Full Text] [Related]
17. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.
Liu Z; Wei S; Ma H; Zhao M; Myers JN; Weber RS; Sturgis EM; Wei Q
Carcinogenesis; 2011 Nov; 32(11):1668-74. PubMed ID: 21934093
[TBL] [Abstract][Full Text] [Related]
18. 3'UTR SNPs and Haplotypes in the GATA4 Gene Contribute to the Genetic Risk of Congenital Heart Disease.
Pulignani S; Vecoli C; Sabina S; Foffa I; Ait-Ali L; Andreassi MG
Rev Esp Cardiol (Engl Ed); 2016 Aug; 69(8):760-5. PubMed ID: 27118528
[TBL] [Abstract][Full Text] [Related]
19. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
[TBL] [Abstract][Full Text] [Related]
20. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
